A detailed history of Bridgefront Capital, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Bridgefront Capital, LLC holds 2,063 shares of DGX stock, worth $282,816. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,063
Previous 3,708 44.36%
Holding current value
$282,816
Previous $507,000 44.38%
% of portfolio
0.11%
Previous 0.22%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$137.09 - $137.09 $225,513 - $225,513
-1,645 Reduced 44.36%
2,063 $282,000
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $466,874 - $535,212
3,708 New
3,708 $507,000
Q3 2023

Nov 14, 2023

BUY
$121.86 - $144.92 $693,261 - $824,449
5,689 New
5,689 $693,000
Q2 2022

Aug 12, 2022

BUY
$127.07 - $145.39 $558,472 - $638,989
4,395 New
4,395 $584,000
Q1 2021

May 17, 2021

SELL
$114.63 - $133.34 $444,535 - $517,092
-3,878 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$112.7 - $128.05 $437,050 - $496,577
3,878 New
3,878 $462,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.